PINK1 Protects against Oxidative Stress by Phosphorylating Mitochondrial Chaperone TRAP1
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Mutations in the PTEN induced putative kinase 1 (PINK1) gene cause an autosomal recessive form of Parkinson disease (PD). So far, no substrates of PINK1 have been reported, and the mechanism by which PINK1 mutations lead to neurodegeneration is unknown. Here we report the identification of TNF receptor-associated protein 1 (TRAP1), a mitochondrial molecular chaperone also known as heat shock protein 75 (Hsp75), as a cellular substrate for PINK1 kinase. PINK1 binds and colocalizes with TRAP1 in the mitochondria and phosphorylates TRAP1 both in vitro and in vivo. We show that PINK1 protects against oxidative-stress-induced cell death by suppressing cytochrome c release from mitochondria, and this protective action of PINK1 depends on its kinase activity to phosphorylate TRAP1. Moreover, we find that the ability of PINK1 to promote TRAP1 phosphorylation and cell survival is impaired by PD-linked PINK1 G309D, L347P, and W437X mutations. Our findings suggest a novel pathway by which PINK1 phosphorylates downstream effector TRAP1 to prevent oxidative-stress-induced apoptosis and implicate the dysregulation of this mitochondrial pathway in PD pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Phosphorylation of TRAP1 by Wild-Type and Mutant PINK1 (A) In vitro kinase assays were performed by incubation of purified TRAP1 with [γ32-P] ATP in the absence (control) or presence of FLAG-tagged wild-type (WT) or mutant PINK1 proteins as indicated. Phosphorylated TRAP1 was visualized by autoradiography (top panel). PINK1 and TRAP1 proteins used in the kinase assays were shown by immunoblotting with anti-TRAP1 (middle panel) and anti-FLAG antibodies (bottom panel). (B) Normalized levels of in vitro TRAP1 phosphorylation by wild-type or mutant PINK1. Data represent mean ± standard error of the mean (SEM) from three independent experiments. *Significantly different from the wild-type PINK1 (p < 0.01). (C) PC12 cells expressing wild-type or mutant PINK1 or vector-transfected controls were treated with 400 μM H2O2 as indicated. In vivo phosphorylation of endogenous TRAP1 was determined by immunoprecipitation with anti-TRAP1 antibody followed by immunoblotting using anti-phosphoserine (upper panel) and anti-TRAP1 (lower panel) antibodies. (D) Normalized levels of in vivo TRAP1 phosphorylation by wild-type or mutant PINK1. Data represent mean ± SEM from three independent experiments. aSignificantly different from the corresponding H2O2-treated vector-transfected controls (p < 0.01). bSignificantly different from the wild-type PINK1-transfected cells (p < 0.01). AU, arbitrary units.](https://figures.cochat.ai/paper-figures/17d4ebdc4d0a46a99e4bb1385a64faa3/pink1-protects-against-oxidative-stress-by-phosphorylating-mitochondrial-figure-3.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Normally, PINK1 serves a protective role by helping to produce the PTEN-induced kinase protein, which shields mitochondria from damage caused by the reactive oxygen species (ROS) [140].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [140]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked
Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T.-I., Jones, D. P., & Wang, X. (1997) · Science · doi:10.1126/science.275.5303.1129 · Cited by 4,911 · cited 1×
“Biochemical assays of cytochrome c release were performed as described [40].”
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481 · cited 2×
“served serine/threonine kinase domain [5].”
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283 · cited 1×
“Postmortem analyses reveal a deficiency in the mitochondrial complex I function in patients with sporadic PD [3].”
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 1,994
Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin
Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A., & Guo, M. (2006) · Nature · doi:10.1038/nature04779 · Cited by 1,788 · cited 1×
“loss of PINK1 leads to mitochondrial defects and degeneration of muscle and dopaminergic neurons [”
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., & Marsden, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,756
Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin
Park, J., Lee, S. B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J.-M., et al. (2006) · Nature · doi:10.1038/nature04788 · Cited by 1,705 · cited 1×
“dopaminergic neurons [17–20].”
Ninomiya-Tsuji, J., Kishimoto, K., Hiyama, A., Inoue, J.-I., Cao, Z., & Matsumoto, K. (1999) · Nature · doi:10.1038/18465 · Cited by 1,182 · cited 1×
“In vitro kinase assays were performed as described [33] by incubation of affinity-purified FLAG-tagged wild-type or mutant PINK1 with TRAP1 for 20 min at 30 8C in 100 ll of reaction buffer containing 50 mM Tris-HCl (pH 7.”
Canet-Avilés, R. M., Wilson, M. A., Miller, D. W., Ahmad, R., McLendon, C., Bandyopadhyay, S., Baptista, M. J., Ringe, D., Petsko, G. A., & Cookson, M. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402959101 · Cited by 1,116 · cited 1×
“PC12 cells were treated with H2O2 as indicated, and cell viability was assessed using the 3-(4,5dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay as described [38].”
Modulation of neurodegeneration by molecular chaperones
Muchowski, P. J., & Wacker, J. L. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1587 · Cited by 1,024 · cited 1×
“of cellular processes, including cell survival and apoptosis [24, 25 ].”
Research works printed but not linked: 41
- Lang, 1998, N Engl J Med, 339, 1044
- Farrer, 2006, Nat Rev Genet, 7, 306
- Schapira, 1989, Lancet, 1, 1269
- Betarbet, 2002, Bioessays, 24, 308
- Valente, 2004, Science, 304, 1158
- Hatano, 2004, Ann Neurol, 56, 424
- Bonifati, 2005, Neurology, 65, 87
- Zadikoff, 2006, Mov Disord, 21, 875
- Hedrich, 2006, Arch Neurol, 63, 833
- Criscuolo, 2006, Mov Disord, 21, 1265
- Beilina, 2005, Proc Natl Acad Sci U S A, 102, 5703
- Silvestri, 2005, Hum Mol Genet, 14, 3477
- Gandhi, 2006, Brain, 129, 1720
- Nakajima, 2003, Cancer Lett, 201, 195
- Petit, 2005, J Biol Chem, 280, 34025
- Deng, 2005, Biochem Biophys Res Commun, 337, 1133
- Clark, 2006, Nature, 441, 1162
- Park, 2006, Nature, 441, 1157
- Wang, 2006, Proc Natl Acad Sci U S A, 103, 13520
- Yang, 2006, Proc Natl Acad Sci U S A, 103, 10793
- Song, 1995, J Biol Chem, 270, 3574
- Chen, 1996, Mol Cell Biol, 16, 4691
- Felts, 2000, J Biol Chem, 275, 3305
- Beere, 2005, J Clin Invest, 115, 2633
- Muchowski, 2005, Nat Rev Neurosci, 6, 11
- Masuda, 2004, J Biol Chem, 279, 42503
- Sim, 2006, Hum Mol Genet, 15, 3251
- Olzmann, 2004, J Biol Chem, 279, 8506
- Chin, 2000, J Biol Chem, 275, 1191
- Choi, 2004, J Biol Chem, 279, 13256
- Choi, 2006, J Biol Chem, 281, 10816
- Chin, 2001, J Biol Chem, 276, 7069
- Ninomiya-Tsuji, 1999, Nature, 398, 252
- Lewis Carl, 1993, J Histochem Cytochem, 41, 1273
- Li, 2002, J Biol Chem, 277, 28212
- Hovius, 1990, Biochim Biophys Acta, 1021, 217
- Kirk, 2006, J Cell Sci, 119, 4689
- Canet-Aviles, 2004, Proc Natl Acad Sci U S A, 101, 9103
- Chen, 2001, Proc Natl Acad Sci U S A, 98, 7783
- Yang, 1997, Science, 275, 1129
- Sherer, 2002, J Neurosci, 22, 7006
Cited by
The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
Pickrell, A. M., & Youle, R. J. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.007 · Cited by 2,310
“Omi/HtrA2, a serine protease, and tumor necrosis factor receptor-associated protein 1 (TRAP-1), a chaperone protein, both have been reported to be targets of PINK1 (Plun-Favreau et al., 2007; Pridgeon et al., 2007).”
BackgroundHSP90 at the hub of protein homeostasis: emerging mechanistic insights
Taipale, M., Jarosz, D. F., & Lindquist, S. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2918 · Cited by 1,818
Targeting the dynamic HSP90 complex in cancer
Trepel, J., Mollapour, M., Giaccone, G., & Neckers, L. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2887 · Cited by 1,514
Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL
Jin, S. M., Lazarou, M., Wang, C., Kane, L. A., Narendra, D. P., & Youle, R. J. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201008084 · Cited by 1,375
“Finally, in some studies, PINK1 has been localized to the inner membrane with its kinase domain facing the intermembrane space (Silvestri et al., 2005; Plun-Favreau et al., 2007; Pridgeon et al., 2007).”
BackgroundMitochondria in neuroplasticity and neurological disorders
Mattson, M. P., Gleichmann, M., & Cheng, A. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.010 · Cited by 1,081
Dagda, R. K., Cherra, S. J., Kulich, S. M., Tandon, A., Park, D., & Chu, C. T. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808515200 · Cited by 954
Mitochondrial dysfunction and oxidative stress in Parkinson's disease
Subramaniam, S. R., & Chesselet, M.-F. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.04.004 · Cited by 913
Kondapalli, C., Kazlauskaite, A., Zhang, N., Woodroof, H. I., Campbell, D. G., Gourlay, R., Burchell, L., Walden, H., Macartney, T. J., Deak, M., et al. (2012) · Open Biology · doi:10.1098/rsob.120080 · Cited by 940
“Pridgeon JW, Olzmann JA, Chin LS, Li L. 2007 PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1.”
BackgroundInfluentialMitochondrial biology and oxidative stress in Parkinson disease pathogenesis
Henchcliffe, C., & Beal, M. F. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0924 · Cited by 783
Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress
Gautier, C. A., Kitada, T., & Shen, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802076105 · Cited by 698
“TRAP1 and HtrA2, two mitochondrial proteins with chaperone functions, have been identified as putative downstream effectors for PINK1 (13, 36).”
The HSP90 Family: Structure, Regulation, Function, and Implications in Health and Disease
Hoter, A., El-Sabban, M. E., & Naim, H. Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092560 · Cited by 693
“Additionally, the mitochondrial homologue TRAP1 is subject to phosphorylation [60,68].”
BackgroundMitochondrial dysfunction in Parkinson's disease
Winklhofer, K. F., & Haass, C. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.08.013 · Cited by 688
“activity of PINK1 against oxidative stress is dependent on TRAP1 phosphorylation [139].”
BackgroundGandhi, S., Wood-Kaczmar, A., Yao, Z., Plun-Favreau, H., Deas, E., Klupsch, K., Downward, J., Latchman, D. S., Tabrizi, S. J., Wood, N. W., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.02.013 · Cited by 682
“, 2007) and TRAP1 (Pridgeon et al., 2007) have been identified as downstream effectors of PINK1 function.”
BackgroundPINK1 is degraded through the N-end rule pathway
Yamano, K., & Youle, R. J. (2013) · Autophagy · doi:10.4161/auto.24633 · Cited by 672
“Furthermore, PINK1(1-155)-YFP, a mutant with an N-end stabilizing residue was stably localized in the cytosol (Fig.”
BackgroundMetabolic control of cell death
Green, D. R., Galluzzi, L., & Kroemer, G. (2014) · Science · doi:10.1126/science.1250256 · Cited by 647
Exner, N., Lutz, A. K., Haass, C., & Winklhofer, K. F. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.170 · Cited by 642
“Pridgeon et al (2007) reported that PINK1 phosphorylates TRAP1 (TNF receptor-associated protein 1), a mitochondrial chaperone of the Hsp90 family also known as Hsp75.”
PINK1- and Parkin-mediated mitophagy at a glance
Jin, S. M., & Youle, R. J. (2012) · Journal of Cell Science · doi:10.1242/jcs.093849 · Cited by 635
“…is controversial, and the previously reported substrates of PINK1, such as the tumor necrosis factor (TNF)-receptor-associated protein 1 (TRAP1) (Pridgeon et al., 2007) and serine protease HTRA2 (also known as OMI) (Plun- Journal of Cell Science 125 (4) Jo ur na l o f C el l S ci en…”
BackgroundWhat Genetics Tells us About the Causes and Mechanisms of Parkinson's Disease
Corti, O., Lesage, S., & Brice, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00022.2010 · Cited by 611
Basit, F., van Oppen, L. M., Schöckel, L., Bossenbroek, H. M., van Emst-de Vries, S. E., Hermeling, J. C., Grefte, S., Kopitz, C., Heroult, M., HGM Willems, P., et al. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.133 · Cited by 565
“PINK1 can phosphorylate TRAP1 to prevent apoptosis induced by oxidative stress.(53) This would mean that PINK1 knockdown should reduce TRAP1 activity, thereby potentiating BAY-induced cell death.”
BackgroundNuytemans, K., Theuns, J., Cruts, M., & Van Broeckhoven, C. (2010) · Human Mutation · doi:10.1002/humu.21277 · Cited by 563
“…2009], ROS formation, mitochondrial respiration efficacy [Liu et al., 2009], and opening of the mitochondrial permeability transition pore [Gandhi et al., 2009] as well as by interaction with cell death inhibitors and chaperones [Plun-Favreau et al., 2007; Pridgeon et al., 2007; Wang et al., 2007].”
BackgroundInfluentialQuality control of mitochondria: protection against neurodegeneration and ageing
Tatsuta, T., & Langer, T. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601972 · Cited by 523
“While it remains to be clarified whether HtrA2 is a PINK1 substrate, PINK1-mediated phosphorylation has been demonstrated for TRAP1, a putative molecular chaperone with significant homology to the HSP90AA1 family (Pridgeon et al, 2007).”
BackgroundPINK1 cleavage at position A103 by the mitochondrial protease PARL
Deas, E., Plun-Favreau, H., Gandhi, S., Desmond, H., Kjaer, S., Loh, S. H. Y., Renton, A. E. M., Harvey, R. J., Whitworth, A. J., Martins, L. M., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddq526 · Cited by 504
“PINK1 is known to be involved in protection from oxidative stress (17,25,26) and we have previously shown that PINK1 deficiency results in an increase in cytosolic and mitochondrial ROS production (18,19).”
BackgroundThe mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1
Plun-Favreau, H., Klupsch, K., Moisoi, N., Gandhi, S., Kjaer, S., Frith, D., Harvey, K., Deas, E., Harvey, R. J., McDonald, N., et al. (2007) · Nature Cell Biology · doi:10.1038/ncb1644 · Cited by 479
“We are currently investigating whether the newly identified PINK1 substrate, the heat shock protein TRAP”
BackgroundMitochondrial Dysfunction in Parkinson’s Disease
Moon, H. E., & Paek, S. H. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.2.103 · Cited by 455
“Moreover, PINK1 has been shown to phosphorylate the mitochondrial molecular chaperone heat shock protein 75 kDa [50].”
BackgroundThe Hsp90 molecular chaperone: an open and shut case for treatment
Pearl, L. H., Prodromou, C., & Workman, P. (2008) · Biochemical Journal · doi:10.1042/bj20071640 · Cited by 447
Regulation of Tumor Cell Mitochondrial Homeostasis by an Organelle-Specific Hsp90 Chaperone Network
Kang, B. H., Plescia, J., Dohi, T., Rosa, J., Doxsey, S. J., & Altieri, D. C. (2007) · Cell · doi:10.1016/j.cell.2007.08.028 · Cited by 443
“Expression of TRAP-1 in WS-1 (Figure 6I) or HFF (Figure S5) fibroblasts strongly counteracted apoptosis induced by various concentrations of staurosporine, in agreement with recent observations (Pridgeon et al., 2007), whereas control transfectants were ineffective.”
ResultMorais, V. A., Verstreken, P., Roethig, A., Smet, J., Snellinx, A., Vanbrabant, M., Haddad, D., Frezza, C., Mandemakers, W., Vogt‐Weisenhorn, D., et al. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900006 · Cited by 434
“…mitochondrial proteins TRAP1 (TNF receptor-associated protein 1), Htr2a (5-hydroxytryptamine (serotonin) receptor 2a)/OMI (Plun-Favreau et al, 2007; Pridgeon et al, 2007) and also Parkin (Kim et al, 2008), and associates with Hsp90 (heat shock protein 90)/Cdc37 (cell division cycle 37) chaperones…”
Mitochondrial Diseases of the Brain
Chaturvedi, R. K., & Flint Beal, M. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.03.018 · Cited by 413
“PINK mediated TRAP1 phosphorylation and cell survival is impaired by PD associated mutations in PINK1 genes, suggesting mitochondrial dysfunction in PD [115].”
BackgroundParkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation
Xiong, H., Wang, D., Chen, L., Choo, Y. S., Ma, H., Tang, C., Xia, K., Jiang, W., Ronai, Z., Zhuang, X., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37617 · Cited by 392
Gispert, S., Ricciardi, F., Kurz, A., Azizov, M., Hoepken, H.-H., Becker, D., Voos, W., Leuner, K., Müller, W. E., Kudin, A. P., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005777 · Cited by 381
“In view of the report on PINK1 phosphorylating the mitochondrial chaperone TRAP1 [7] and the role of chaperones in mitochondrial preprotein import, we assessed the residual Figure 3.”
BackgroundMeissner, C., Lorenz, H., Weihofen, A., Selkoe, D. J., & Lemberg, M. K. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07253.x · Cited by 376
Liu, S., Sawada, T., Lee, S., Yu, W., Silverio, G., Alapatt, P., Millan, I., Shen, A., Saxton, W., Kanao, T., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002537 · Cited by 371
Neurodegeneration and Inflammation—An Interesting Interplay in Parkinson’s Disease
Marogianni, C., Sokratous, M., Dardiotis, E., Hadjigeorgiou, G. M., Bogdanos, D., & Xiromerisiou, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228421 · Cited by 366
“Missense mutations in the PTEN-induced putative kinase1 (PINK1) gene are the cause for an early-onset form of Parkinson’s that is recessively inherited [82].”
BackgroundMitochondrial Quality Control Mediated by PINK1 and Parkin: Links to Parkinsonism
Narendra, D., Walker, J. E., & Youle, R. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a011338 · Cited by 345
“2007), TRAP1 (Pridgeon et al. 2007), PGAM5 (Imai et al.”
BackgroundJackson, S. E. (2012) · Topics in Current Chemistry · doi:10.1007/128_2012_356 · Cited by 338
“PINK-1 phosphorylates TRAP-1, illustrating that like Hsp90 its activity is controlled by post-translational modification, and the phosphorylated TRAP-1 prevents mitochondrial dysfunction and oxidative stress induced apoptosis [227].”
BackgroundImpaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease
Büeler, H. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.03.006 · Cited by 327
Molecular Mechanisms of Mitochondrial Autophagy/Mitophagy in the Heart
Saito, T., & Sadoshima, J. (2015) · Circulation Research · doi:10.1161/circresaha.116.303790 · Cited by 322
“This may be because Pink1 has additional functions besides Parkin-mediated autophagy, including phosphorylation of TNF receptor-associated protein 1 (TRAP1), to protect against cell death.(141)”
PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons
Wood-Kaczmar, A., Gandhi, S., Yao, Z., Abramov, A. S. Y., Miljan, E. A., Keen, G., Stanyer, L., Hargreaves, I., Klupsch, K., Deas, E., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002455 · Cited by 316
“Silencing of TRAP1 in tumor cells also causes mitochondrial swelling, loss of ym, rapid increase in intracellular ROS generation and release of cytochrome C, identical to the effects of PINK1 knockdown [43,53].”
The kinase domain of mitochondrial PINK1 faces the cytoplasm
Zhou, C., Huang, Y., Shao, Y., May, J., Prou, D., Perier, C., Dauer, W., Schon, E. A., & Przedborski, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802814105 · Cited by 315
“TIM23, an essential component of the mitochondrial protein import machinery located in the IMM, has been used as a marker to establish the localization of PINK1 inside the mitochondria (6).”
BackgroundInfluentialPINK1 signalling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer’s disease
Du, F., Yu, Q., Yan, S., Hu, G., Lue, L.-F., Walker, D. G., Wu, L., Yan, S. F., Tieu, K., & Yan, S. S. (2017) · Brain · doi:10.1093/brain/awx258 · Cited by 306
“Notably, to address whether PINK1 kinase activity is required for amyloid pathology and amyloid-b-induced defects, we examined the effect of inactive mutant forms of PINK1, mPINK1 (L347P, defined as a loss-of-function form of PINK1) or triple-mPINK1 (PINK1 kinase dead mutant, K219A, D362A and D384A) as a classical kin…”
BackgroundInfluentialThe Therapeutic Potential of Metformin in Neurodegenerative Diseases
Rotermund, C., Machetanz, G., & Fitzgerald, J. C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00400 · Cited by 304
“In this pathway, TRAP1 and themitochondrial serine protease HtrA2 are both targets of the PD protein PINK1 (305, 306).”
BackgroundMitochondrial gateways to cancer
Galluzzi, L., Morselli, E., Kepp, O., Vitale, I., Rigoni, A., Vacchelli, E., Michaud, M., Zischka, H., Castedo, M., & Kroemer, G. (2010) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.08.002 · Cited by 300
Weihofen, A., Thomas, K. J., Ostaszewski, B. L., Cookson, M. R., & Selkoe, D. J. (2009) · Biochemistry · doi:10.1021/bi8019178 · Cited by 290
“The mitochondrial localization of Pink1 (5,6), alterations in mitochondrial morphology, dynamics and function caused by Pink1 deficiency (7-11), and the discovery of a mitochondrial Pink1 substrate, TRAP1 (12), all point to a central role of Pink1 in normal mitochondrial function.”
BackgroundHypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model
Hamamichi, S., Rivas, R. N., Knight, A. L., Cao, S., Caldwell, K. A., & Caldwell, G. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711018105 · Cited by 268
Integrating Pathways of Parkinson's Disease in a Molecular Interaction Map
Fujita, K. A., Ostaszewski, M., Matsuoka, Y., Ghosh, S., Glaab, E., Trefois, C., Crespo, I., Perumal, T. M., Jurkowski, W., Antony, P. M. A., et al. (2014) · Molecular Neurobiology · doi:10.1007/s12035-013-8489-4 · Cited by 273
“Control of mitochondrial turnover and protection against oxidative stress are mediated via the kinase activity of PINK1 targeting Parkin [71], HTRA2 [72] and TRAP1[73] proteins.”
BackgroundA neo-substrate that amplifies catalytic activity of Parkinson's-disease-related kinase PINK1
Hertz, N. T., Berthet, A., Sos, M. L., Thorn, K. S., Burlingame, A. L., Nakamura, K., & Shokat, K. M. (2013) · Cell · doi:10.1016/j.cell.2013.07.030 · Cited by 275
“The PINK1 pathway has also been linked to the induction of mitochondrial biogenesis and the reduction of mitochondriainduced apoptosis in neurons, the latter phenotype due at least in part to the effect of PINK1 on mitochondrial motility, a neuron-specific phenotype (Deng et al., 2005; Petit et al., 2005; Pridgeon et…”
InfluentialA Senescence-Centric View of Aging: Implications for Longevity and Disease
Borghesan, M., Hoogaars, W. M. H., Varela-Eirin, M., Talma, N., & Demaria, M. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.07.002 · Cited by 267
“Paradoxically, increased autophagic flux is necessary to counteract the endoplasmic reticulum stress and unfolded protein response (UPR), in part deriving from the high load of SASP secretion and thus contributing to survival of senescent cells [19].”
BackgroundThe Mitochondrial Chaperone TRAP1 Promotes Neoplastic Growth by Inhibiting Succinate Dehydrogenase
Sciacovelli, M., Guzzo, G., Morello, V., Frezza, C., Zheng, L., Nannini, N., Calabrese, F., Laudiero, G., Esposito, F., Landriscina, M., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.019 · Cited by 264
Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP
Haque, M. E., Thomas, K. J., D'Souza, C., Callaghan, S., Kitada, T., Slack, R. S., Fraser, P., Cookson, M. R., Tandon, A., & Park, D. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705363105 · Cited by 263
Characterization of PINK1 processing, stability, and subcellular localization
Lin, W., & Kang, U. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05398.x · Cited by 262
The Parkinson-associated protein PINK1 interacts with Beclin1 and promotes autophagy
Michiorri, S., Gelmetti, V, Giarda, E., Lombardi, F., Romano, F., Marongiu, R., Nerini-Molteni, S., Sale, P., Vago, R., Arena, G., et al. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.200 · Cited by 260
Mitochondrial Dysfunction in Parkinson’s Disease—Cause or Consequence?
Chen, C., Turnbull, D. M., & Reeve, A. K. (2019) · Biology · doi:10.3390/biology8020038 · Cited by 258
“For example, PINK1 has been proposed to be involved in this pathway through its interaction with HTRA serine peptidase 2 (HTRA2, PARK13, OMIM 606441) [109] and tumor necrosis factor receptor-associated protein 1 (TRAP1) [110].”
BackgroundMai, S., Klinkenberg, M., Auburger, G., Bereiter-Hahn, J., & Jendrach, M. (2010) · Journal of Cell Science · doi:10.1242/jcs.059246 · Cited by 256
“Jo ur na l o f C el l S ci en ce 921Stress resistance of senescent cells This conclusion correlates with data which show that overexpression of PINK1 can protect cells against different stressors (Petit et al., 2005; Pridgeon et al., 2007; Haque et al., 2008).”
BackgroundResultInfluentialMitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis
Banerjee, R., Starkov, A. A., Beal, M. F., & Thomas, B. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.11.007 · Cited by 253
“These include a) TNF receptor-associated protein 1 (TRAP1), a mitochondrial molecular chaperone also known as heat shock protein 75 [190] and b) HtrA2, a mitochondrial serine protease, also known as Omi which is also a candidate gene for PARK13 [76].”
BackgroundZhou, L.-Y., Zhai, M., Huang, Y., Xu, S., An, T., Wang, Y.-H., Zhang, R.-C., Liu, C.-Y., Dong, Y.-H., Wang, M., et al. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0206-4 · Cited by 254
Programmed Cell Death in Parkinson's Disease
Venderova, K., & Park, D. S. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009365 · Cited by 247
“Overexpression of wild-type PINK1 has a prosurvival effect (Valente et al. 2004; Petit et al. 2005; Pridgeon et al. 2007) by inhibiting opening of the mitochondrial PTP (Wang et al.”
BackgroundPINK1 is recruited to mitochondria with parkin and associates with LC3 in mitophagy
Kawajiri, S., Saiki, S., Sato, S., Sato, F., Hatano, T., Eguchi, H., & Hattori, N. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.02.016 · Cited by 245
“Although PINK1 overexpression is protective against oxidative stress-induced apoptotic cell death [2,19,20], excess wild-type PINK1 without parkin overexpression does not elicit mitochondrial autophagy [12].”
BackgroundKang, B. H., Plescia, J., Song, H. Y., Meli, M., Colombo, G., Beebe, K., Scroggins, B., Neckers, L., & Altieri, D. C. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37613 · Cited by 240
“Consistent with this model, mitochondrial TRAP-1 (20) has been recently implicated in protection from apoptosis induced by oxidative stimuli (51, 52).”
Barazzuol, L., Giamogante, F., Brini, M., & Calì, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051772 · Cited by 232
“Among them there are the High Temperature Requirement Protein A2, also known as HTRA2/Omi protease [26], the chaperone tumor necrosis factor receptor associated protein 1 (TRAP1) [27] in the IMS, and the complex I subunit NDUFA10 (NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10) located in the IMM [28].”
BackgroundPINK1-induced mitophagy promotes neuroprotection in Huntington’s disease
Khalil, B., El Fissi, N., Aouane, A., Cabirol-Pol, M.-J., Rival, T., & Liévens, J.-C. (2015) · Cell Death & Disease · doi:10.1038/cddis.2014.581 · Cited by 230
“The mitochondrial chaperone TRAP1 might be a direct substrate of PINK1, allowing the refolding/removal of misfolded proteins and preventing apoptotic cytochrome C release.(18) However, our data suggest that TRAP1 overexpression does not mimic PINK1-mediated protection in HD flies.”
BackgroundChaperone–protease networks in mitochondrial protein homeostasis
Voos, W. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.06.005 · Cited by 223
Mitophagy and Parkinson's disease: The PINK1–parkin link
Deas, E., Wood, N. W., & Plun-Favreau, H. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.08.007 · Cited by 222
“as the TRAP1 chaperone protein and the Omi/HtrA2 protease [129,130].”
BackgroundMechanisms of selective autophagy and mitophagy: Implications for neurodegenerative diseases
Chu, C. T. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.07.015 · Cited by 218
Oxidative stress factors in Parkinson’s disease
Dorszewska, J., Kowalska, M., Prendecki, M., Piekut, T., Kozłowska, J., & Kozubski, W. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.300980 · Cited by 210
“…quality control - Abnormal morphology of mitochondria, abnormal mitophagy - Oxidative stress-induced cell death - Increased mitochondrial ROS and reduced GSH after cytotoxicity Pridgeon et al. (2007); Dagda et al. (2009); Kawajiri et al. (2011); Barodia et al. (2017); Sison et al. (2018) DJ1 -”
BackgroundCui, M., Tang, X., Christian, W. V., Yoon, Y., & Tieu, K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.066662 · Cited by 207
Oxidative and nitrative protein modifications in Parkinson's disease
Danielson, S. R., & Andersen, J. K. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.03.005 · Cited by 202
“Phosphorylation of TRAP1 by PINK1 protected cells from oxidative stress by preventing cytochrome c release from mitochondria suggesting that the serine/ threonine kinase activity of PINK1 may be involved in preventing apoptotic neuronal cell death in PD [80].”
BackgroundThe multifaceted regulation of mitophagy by endogenous metabolites
Zhang, T., Liu, Q., Gao, W., Sehgal, S. A., & Wu, H. (2022) · Autophagy · doi:10.1080/15548627.2021.1975914 · Cited by 197
“[67,68] and mitochondrial chaperone [69].”
Truban, D., Hou, X., Caulfield, T. R., Fiesel, F. C., & Springer, W. (2016) · Journal of Parkinson’s Disease · doi:10.3233/jpd-160989 · Cited by 237
“Among the reported PINK1 substrates are the PD-linked serine protease HTRA2/Omi (PARK13) [86], the chaperone TRAP1 [87] in the intermembrane space and the complex I subunit NDUFA10 [88] located on the IMM.”
BackgroundOxidative Stress-Induced Signaling Pathways Implicated in the Pathogenesis of Parkinson’s Disease
Gaki, G. S., & Papavassiliou, A. G. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-014-8294-x · Cited by 200
“…SOD Superoxide dismutase STAT Signal transducer and activator of transcription SVZ Subventricular zone TCF/ LEF T-cell factor/lymphoid enhancer-binding factor TNF-a Tumor necrosis factor alpha TRAP1 TNF receptor-associated protein UPS Ubiquitin–proteasome system DWm Mitochondrial membrane potential”
BackgroundGegg, M. E., Cooper, J. M., Schapira, A. H. V., & Taanman, J.-W. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004756 · Cited by 198
“Disruption of PINK1-mediated phosphorylation of either TRAP1 or HtrA2 resulted in increased cell death.”
Sämann, J., Hegermann, J., von Gromoff, E., Eimer, S., Baumeister, R., & Schmidt, E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808255200 · Cited by 193
Franco-Iborra, S., Vila, M., & Perier, C. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00342 · Cited by 194
“TRAP1 was also decreased in A53T α-synuclein-expressing flies, resulting in an increased sensitivity to oxidative stress andmotor alterations that were rescued after TRAP1 overexpression, thus providing a link between PINK1 and α-synuclein through TRAP1 (Butler et al., 2012).”
BackgroundInfluentialTRAP-1, the mitochondrial Hsp90
Altieri, D. C., Stein, G. S., Lian, J. B., & Languino, L. R. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.08.007 · Cited by 186
Akundi, R. S., Huang, Z., Eason, J., Pandya, J. D., Zhi, L., Cass, W. A., Sullivan, P. G., & Büeler, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016038 · Cited by 187
“In cultured cells, PINK1 protects against oxidative stress-induced cytochrome c release and apoptosis through phosphorylation of the mitochondrial chaperone TRAP1 [5].”
Mitophagy and Oxidative Stress: The Role of Aging
De Gaetano, A., Gibellini, L., Zanini, G., Nasi, M., Cossarizza, A., & Pinti, M. (2021) · Antioxidants · doi:10.3390/antiox10050794 · Cited by 184
Mitochondrial DNA damage and repair in neurodegenerative disorders
Yang, J.-L., Weissman, L., Bohr, V. A., & Mattson, M. P. (2008) · DNA Repair · doi:10.1016/j.dnarep.2008.03.012 · Cited by 186
“Other studies also demonstrated that overexpressing TRAP1 decreases the levels of ROS, caveolin-1, glutathione peroxidase, manganese superoxide dismutase and senescence-associated –galactosidase activity, whereas silencing TRAP1 or decreasing TRAP1 levels causes accumulation of ROS [99,100].”
BackgroundInfluentialSha, D., Chin, L.-S., & Li, L. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddp501 · Cited by 184
Self-citationThe genetic architecture of mitochondrial dysfunction in Parkinson’s disease
Larsen, S. B., Hanss, Z., & Krüger, R. (2018) · Cell and Tissue Research · doi:10.1007/s00441-017-2768-8 · Cited by 181
“TRAP1 is part of established PD signalling pathways, as it has been shown to be phosphorylated and activated by PINK1 (Pridgeon et al. 2007).”
BackgroundLoss of PINK1 Function Affects Development and Results in Neurodegeneration in Zebrafish
Anichtchik, O., Diekmann, H., Fleming, A., Roach, A., Goldsmith, P., & Rubinsztein, D. C. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0979-08.2008 · Cited by 178
“Recently, the phosphorylation of mitochondrial molecular chaperone TRAP1 was attributed to PINK1 (Pridgeon et al., 2007), further strengthening the mitochondrial relevance of PINK1.”
BackgroundMaintaining the brain: insight into human neurodegeneration from Drosophila melanogaster mutants
Lessing, D., & Bonini, N. M. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2563 · Cited by 176
“TRAP1, a mitochondrial chaperone that is phosphorylated in response to oxidative stress, is a recently described in vivo substrate of PINK1 in human cell”
Signal transduction to the permeability transition pore
Rasola, A., Sciacovelli, M., Pantic, B., & Bernardi, P. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.02.022 · Cited by 178
“the Ser/Thr kinase PTEN induced kinase 1 (PINK1) in the mitochondrial matrix, and this phosphorylation was required to prevent oxidative-stress-induced apoptosis [73].”
BackgroundParkin protects mitochondrial genome integrity and supports mitochondrial DNA repair
Rothfuss, O., Fischer, H., Hasegawa, T., Maisel, M., Leitner, P., Miesel, F., Sharma, M., Bornemann, A., Berg, D., Gasser, T., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp327 · Cited by 177
“PINK1 is a mitochondrial protein kinase, which phosphorylates the mitochondrial chaperone TRAP1 (8).”
BackgroundSandebring, A., Thomas, K. J., Beilina, A., van der Brug, M., Cleland, M. M., Ahmad, R., Miller, D. W., Zambrano, I., Cowburn, R. F., Behbahani, H., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005701 · Cited by 176
“One possible PINK1 substrate, TRAP1 [27], is mitochondrial.”
Functional alteration of PARL contributes to mitochondrial dysregulation in Parkinson's disease
Shi, G., Lee, J. R., Grimes, D. A., Racacho, L., Ye, D., Yang, H., Ross, O. A., Farrer, M., McQuibban, G. A., & Bulman, D. E. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr077 · Cited by 171
Mei, Y., Zhang, Y., Yamamoto, K., Xie, W., Mak, T. W., & You, H. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901104106 · Cited by 172
“Proc Natl Acad Sci USA 103(24):9051–9056.”
Rotenone-Induced Model of Parkinson’s Disease: Beyond Mitochondrial Complex I Inhibition
Ibarra-Gutiérrez, M. T., Serrano-García, N., & Orozco-Ibarra, M. (2023) · Molecular Neurobiology · doi:10.1007/s12035-022-03193-8 · Cited by 165
“1 3 oxidative stress and mitochondrial dysfunction [30].”
BackgroundRoles of mitochondria in human disease
Duchen, M. R., & Szabadkai, G. (2010) · Essays in Biochemistry · doi:10.1042/bse0470115 · Cited by 168
Ubiquitination of -synuclein by Siah-1 promotes -synuclein aggregation and apoptotic cell death
Lee, J. T., Wheeler, T. C., Li, L., & Chin, L.-S. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm363 · Cited by 170
“To provide additional evidence supporting an association between Siah-1-mediated a-synuclein ubiquitination and cell vulnerability to proteasome impairment, we performed cytochrome c release assays (50) to examine the effects of Siah-1 overexpression on MG132-induced apoptotic cell death in cells overexpressing wild-t…”
MethodSelf-citationThe role of inflammation in sporadic and familial Parkinson’s disease
Deleidi, M., & Gasser, T. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1352-y · Cited by 167
Chu, C. T. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq143 · Cited by 166
Xu, L., Voloboueva, L. A., Ouyang, Y., & Giffard, R. G. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.125 · Cited by 166
“Journal of Cerebral Blood Flow & Metabolism (2009) 29, 365–374 Heat shock protein 75 has also been postulated to participate in regulation of apoptotic death and reduce release of cytochrome c from mitochondria after oxidative stress (Pridgeon et al, 2007; Taurin et al, 2002).”
Weihofen, A., Ostaszewski, B., Minami, Y., & Selkoe, D. J. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddm334 · Cited by 165
“Loss of phosphorylation activity for Pink1 KD has been verified in vitro (5, 15 ).”
BackgroundGene–environment interactions: Key to unraveling the mystery of Parkinson's disease
Gao, H.-M., & Hong, J.-S. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.03.005 · Cited by 165
Arena, G., Gelmetti, V, Torosantucci, L., Vignone, D., Lamorte, G., De Rosa, P., Cilia, E., Jonas, E. A., & Valente, E. M. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2013.19 · Cited by 164
Mitochondria and Programmed Cell Death in Parkinson's Disease: Apoptosis and Beyond
Perier, C., Bové, J., & Vila, M. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4074 · Cited by 158
“The ability of PINK1 to promote TRAP1 phosphorylation and cell survival was impaired by PD-related or kinase-inactive PINK1 mutations (75).”
InfluentialOxidative Stress: Emerging Mitochondrial and Cellular Themes and Variations in Neuronal Injury
Higgins, G. C., Beart, P. M., Shin, Y. S., Chen, M. J., Cheung, N. S., & Nagley, P. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100321 · Cited by 178
“PINK1 phosphorylates tumor necrosis factor receptor-associated protein (TRAP1, also known as Hsp75) under oxidative stress, which prevents apoptosis [107].”
BackgroundMitophagy: the latest problem for Parkinson's disease
Vives-Bauzá, C., & Przedborski, S. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.11.002 · Cited by 171
Marongiu, R., Spencer, B. J., Crews, L. A., Adame, A., Patrick, C., Trejo, M., Dallapiccola, B., Valente, E. M., & Masliah, E. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05932.x · Cited by 173
Parkinson's disease and cancer: two wars, one front
Devine, M. J., Plun‐Favreau, H., & Wood, N. W. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3150 · Cited by 169
“PINK1 encodes a serine-threonine kinase with an amino-terminal mitochondrial import sequence and it seems to have a role in maintaining mitochondrial integrity in the face of cellular stressor”
PINK1 function in health and disease
Deas, E., Plun‐Favreau, H., & Wood, N. W. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900024 · Cited by 154
“…the identification of the full-length (63 kDa) and both the cleaved forms of the protein (53 kDa and 45 kDa) (Dagda et al, 2009; Exner et al, 2007; Gandhi et al, 2006; Liu et al, 2009; Muqit et al, 2006; Plun-Favreau et al, 2007; Pridgeon et al, 2007; Siddall et al, 2008; Zhou et al, 2008b).”
Background
Metadata
- Authors
- Pridgeon, J. W., Olzmann, J. A., Chin, L.-S., & Li, L.
- Affiliations
- Emory University (US)
- Corresponding author
- Chin, Lih-Shen
- Li, Lian
- Venue
- PLoS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-06-19
- Volume
- 5
- Issue
- 7
- Pages
- e172
- ISSN
- 1544-9173 (ISSN-L)
- 1545-7885
- PMC
- PMC1892574
- OpenAlex
- W2055538245
- Cited by
- 596
- References
- 44
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 11 · 2023: 11 · 2022: 20 · 2021: 29 · 2020: 27 · 2019: 14 · 2018: 25 · 2017: 30 · 2016: 21 · 2015: 36 · 2014: 39 · 2013: 39 · 2012: 45
- FWCI
- 42.37
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Biology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- National Institute on Aging (AG021489, R01AG021489)
- National Institute of Neurological Disorders and Stroke (F31NS054597, NS-047199, R01NS047199, NS050650, R01NS050650)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- PINK1, TRAP1, Parkinson's disease, oxidative stress, mitochondrial chaperone, protein phosphorylation, cytochrome c release, apoptosis, PINK1 mutations, neurodegeneration
- MeSH terms
- PTEN-Induced Putative Kinase, Animals, Base Sequence, HeLa Cells, Humans, Mitochondria, Phosphorylation, Protein Binding, Protein Kinases, Recombinant Proteins, Substrate Specificity, Transfection, PC12 Cells, Apoptosis, Point Mutation, Oxidative Stress, HSP90 Heat-Shock Proteins, Parkinsonian Disorders, RNA, Small Interfering, Cytochromes c, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.